Skip to main content

Table 2 Patient-complaints, healthcare professionals’ suspicion of ACT therapeutic ineffectiveness and number of malaria patients seen in the past 4 weeks, Uganda, 2018

From: Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting

Patient complaints of ACT therapeutic ineffectiveness received in the past 4 weeks

Cadre

No. HCPs

Received patient complaints

No. complaints received

Complaints per HCP per 4 weeks

Overall

685

285 (42%)

1147

1.67

Medical officer

110

46 (42%)

179

1.63

Pharmacist/pharmacy technician

92

36 (39%)

148

1.61

Nurse

334

138 (41%)

559

1.67

Clinical officer

114

60 (53%)

247

2.17

Other

35

5 (14%)

14

0.40

Suspicion of ACT therapeutic ineffectiveness in the past 4 weeks

Cadre

No. HCPs

Suspected ACT treatment failures

No. suspected ACT therapeutic ineffectiveness

Suspicions per HCP per 4 weeks

Overall

685

228 (33%)

920

1.34

Medical officer

110

30 (27%)

116

1.05

Pharmacist/pharmacy technician

92

21 (23%)

68

0.74

Nurse

334

122 (37%)

499

1.49

Clinical officer

114

50 (44%)

215

1.89

Other

35

5 (14%)

22

0.63

Number of malaria patients seen in the past 4 weeks

Medical officer

No. HCPs

Mean (SD) patients

No. patients seen per day

Patients seen per HCP per 4 weeks

Overall

685

8.97

6142

251

Medical officer

110

6.85

754

192

Pharmacist/pharmacy technician

92

9.98

918

279

Nurse

334

9.22

3080

258

Clinical officer

114

9.25

1055

259

Other

35

9.57

335

268

  1. ACT: Artemisinin-based combination therapy; HCP: healthcare professional; Thus, the ACT Therapeutic ineffectiveness suspicion rate by HCPs is 0.80 (1.34/1.67) per patient-complaint